OR13C6P

Across TCGA pan-cancer cohorts, OR13C6P RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated OR13C6P data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher OR13C6P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OR13C6P expression acts as an unfavorable survival marker.

UVM, BLCA, and TGCT are the cancer types where OR13C6P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	DFS	Tertile	All	0.142	0.754	<.001	72	view →
BLCA	DFS	Tertile	All	0.087	0.346	<.001	60	view →
TGCT	OS	Tertile	All	0.895	0.993	.003	48	view →
UCS	DFS	Tertile	IV	0.132	0.718	.002	36	view →
LIHC	OS	Tertile	All	0.176	0.709	<.001	36	view →
ESCA	OS	Tertile	All	0.211	0.876	.028	18	view →
PCPG	DFS	Tertile	All	0.781	0.941	.005	18	view →
LGG	OS	Tertile	All	0.219	0.539	.008	9	view →
LUAD	OS	Tertile	III,IV	0.440	0.667	.047	9	view →
THCA	OS	Tertile	IV	0.813	1.000	.039	9	view →
KIRC	DFS	Tertile	All	0.668	0.812	.028	6	view →
SARC	DFS	Tertile	All	0.416	0.610	.040	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

OR13C6P–UVM (DFS)

Open the UVM breakdown →